Nisa Investment Advisors LLC Buys 100 Shares of Innospec Inc. (NASDAQ:IOSP)

Nisa Investment Advisors LLC increased its stake in Innospec Inc. (NASDAQ:IOSP) by 5.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,960 shares of the specialty chemicals company’s stock after purchasing an additional 100 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Innospec were worth $242,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Belpointe Asset Management LLC raised its holdings in shares of Innospec by 226.2% in the 1st quarter. Belpointe Asset Management LLC now owns 274 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 190 shares during the period. Captrust Financial Advisors raised its holdings in shares of Innospec by 74.7% in the 1st quarter. Captrust Financial Advisors now owns 498 shares of the specialty chemicals company’s stock worth $46,000 after purchasing an additional 213 shares during the period. Point72 Middle East FZE bought a new stake in shares of Innospec in the 4th quarter worth approximately $57,000. Point72 Hong Kong Ltd bought a new stake in shares of Innospec in the 1st quarter worth approximately $53,000. Finally, UBS Group AG raised its holdings in shares of Innospec by 71.6% in the 3rd quarter. UBS Group AG now owns 1,009 shares of the specialty chemicals company’s stock worth $86,000 after purchasing an additional 421 shares during the period. Institutional investors own 96.64% of the company’s stock.

Innospec Trading Up 0.2 %

NASDAQ:IOSP opened at $120.82 on Friday. The stock has a market capitalization of $3.01 billion, a PE ratio of 21.69 and a beta of 1.10. The firm’s 50 day moving average is $124.22 and its 200 day moving average is $115.04. Innospec Inc. has a 12 month low of $91.74 and a 12 month high of $131.18.

Innospec (NASDAQ:IOSP) last issued its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.59 by $0.25. Innospec had a net margin of 7.14% and a return on equity of 13.69%. The business had revenue of $494.70 million for the quarter, compared to analysts’ expectations of $479.47 million. During the same quarter in the previous year, the firm posted $1.20 EPS. The business’s revenue for the quarter was down 3.1% compared to the same quarter last year. Research analysts predict that Innospec Inc. will post 6.72 earnings per share for the current year.

Insider Buying and Selling at Innospec

In other Innospec news, Director Leslie J. Parrette bought 410 shares of the stock in a transaction on Thursday, February 22nd. The shares were acquired at an average price of $123.96 per share, with a total value of $50,823.60. Following the acquisition, the director now directly owns 3,620 shares of the company’s stock, valued at approximately $448,735.20. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, SVP David B. Jones sold 2,500 shares of the business’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $125.79, for a total transaction of $314,475.00. Following the completion of the transaction, the senior vice president now directly owns 9,664 shares in the company, valued at approximately $1,215,634.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Leslie J. Parrette purchased 410 shares of Innospec stock in a transaction dated Thursday, February 22nd. The shares were purchased at an average price of $123.96 per share, with a total value of $50,823.60. Following the completion of the transaction, the director now directly owns 3,620 shares in the company, valued at $448,735.20. The disclosure for this purchase can be found here. Insiders have sold 36,500 shares of company stock valued at $4,532,959 in the last 90 days. 1.52% of the stock is currently owned by company insiders.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.